Computerized Tool Improves Cognitive Deficits in Cancer Survivors

This article originally appeared here.
Share this content:
Computerized Tool Improves Cognitive Deficits in Cancer Survivors
Computerized Tool Improves Cognitive Deficits in Cancer Survivors

(HealthDay News) -- Computerized cognitive training improves cognitive deficits associated with pediatric cancer treatment, according to a study published online Oct. 12 in the Journal of Clinical Oncology.

Heather M. Conklin, Ph.D., from St. Jude Children's Research Hospital in Memphis, Tennessee, and colleagues randomly assigned 68 survivors of childhood acute lymphoblastic leukemia or brain tumor with identified cognitive deficits to either computerized cognitive intervention (18 males, 16 females) or waitlist (18 males, 16 females). The intervention consisted of 25 training sessions at home with weekly, telephone-based coaching.

The researchers found that survivors completing the intervention (30 patients; 88 percent) demonstrated greater improvement than controls on measures of working memory, attention, and processing speed. They also showed greater reductions in reported executive dysfunction. From pre- to post-training, functional magnetic resonance imaging showed significant reduction in activation of left lateral prefrontal and bilateral medial frontal areas.

"Study findings show computerized cognitive training is feasible and efficacious for childhood cancer survivors, with evidence for training-related neuroplasticity," conclude the authors.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs